[go: up one dir, main page]

TR200002567T2 - Glisin naklini önleyiciler. - Google Patents

Glisin naklini önleyiciler.

Info

Publication number
TR200002567T2
TR200002567T2 TR2000/02567T TR200002567T TR200002567T2 TR 200002567 T2 TR200002567 T2 TR 200002567T2 TR 2000/02567 T TR2000/02567 T TR 2000/02567T TR 200002567 T TR200002567 T TR 200002567T TR 200002567 T2 TR200002567 T2 TR 200002567T2
Authority
TR
Turkey
Prior art keywords
transport inhibitors
relates
glycine transport
glycine
diseases
Prior art date
Application number
TR2000/02567T
Other languages
English (en)
Turkish (tr)
Inventor
Herman Maria Louis Luyten Walter
Eduard Janssens Frans
Edmond Josephine Kennis Ludo
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of TR200002567T2 publication Critical patent/TR200002567T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TR2000/02567T 1998-03-06 1999-02-26 Glisin naklini önleyiciler. TR200002567T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98200701 1998-03-06

Publications (1)

Publication Number Publication Date
TR200002567T2 true TR200002567T2 (tr) 2000-11-21

Family

ID=8233444

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02567T TR200002567T2 (tr) 1998-03-06 1999-02-26 Glisin naklini önleyiciler.

Country Status (17)

Country Link
EP (1) EP1059922A2 (fr)
JP (1) JP2002505277A (fr)
KR (1) KR20010032968A (fr)
CN (1) CN1292698A (fr)
AU (1) AU3408999A (fr)
BG (1) BG104685A (fr)
BR (1) BR9907951A (fr)
CA (1) CA2322164A1 (fr)
EE (1) EE200000482A (fr)
HR (1) HRP20000523A2 (fr)
HU (1) HUP0101048A2 (fr)
IL (1) IL138228A0 (fr)
NO (1) NO20004431L (fr)
PL (1) PL343435A1 (fr)
SK (1) SK13082000A3 (fr)
TR (1) TR200002567T2 (fr)
WO (1) WO1999044596A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0011997A (pt) 1999-06-28 2002-03-05 Janssen Pharmaceutica Nv Inibidores da replicação do vìrus sincicial respiratório
UA73749C2 (en) * 1999-11-01 2005-09-15 Diarylenines
AU2001254546A1 (en) * 2000-04-20 2001-11-07 Nps Allelix Corp. Aminopiperidines
DE10040016A1 (de) * 2000-08-16 2002-02-28 Boehringer Ingelheim Pharma Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
WO2002019967A2 (fr) 2000-09-08 2002-03-14 Gliatech, Inc. Derives hydraziniques substitues
US6946474B2 (en) 2000-09-14 2005-09-20 Merck & Co., Inc. Nitrogen-containing compounds and their use as glycine transport inhibitors
AR032653A1 (es) 2001-02-09 2003-11-19 Telik Inc Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos.
US7030150B2 (en) 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
DK1703909T3 (da) * 2003-09-09 2009-06-22 Hoffmann La Roche 1-benzoyl-piperazinderivater som glycinoptagelsesinhibitorer til behandling af psykoser
WO2005023260A1 (fr) * 2003-09-09 2005-03-17 F. Hoffmann-La Roche Ag Derives de 1-(2-amino-benzol)-piperazine en tant qu'inhibiteurs de l'absorption du glycocolle pour traiter des psychoses
WO2005058885A2 (fr) * 2003-12-18 2005-06-30 Glaxo Group Limited Composes
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
CN101072762B (zh) * 2004-12-09 2010-06-23 弗·哈夫曼-拉罗切有限公司 苯基-哌嗪甲酮衍生物
BRPI0519054A2 (pt) 2004-12-15 2008-12-23 Hoffmann La Roche fenil metanonas bi e tricÍclicas substituÍdas como inibidores de transportador i de glicina (glyt-1) para o tratamento de doenÇa de alzheimer
PE20061156A1 (es) 2004-12-23 2006-12-16 Glaxo Group Ltd Derivados de benzamida como agentes inhibidores del transportador de glicina
GB0428233D0 (en) * 2004-12-23 2005-01-26 Glaxo Group Ltd Compounds
US7485637B2 (en) 2005-01-04 2009-02-03 Hoffmann-La Roche Inc. Benzoyl-tetrahydropiperidine derivatives
RU2007125380A (ru) * 2005-01-06 2009-02-20 Ф. Хоффманн-Ля Рош Аг (Ch) Сульфанил-замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 (glyt-1) для лечения неврологических и психоневрологических заболеваний
DE602005022113D1 (de) * 2005-01-07 2010-08-12 Hoffmann La Roche Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
BRPI0606730A2 (pt) * 2005-01-18 2009-07-14 Hoffmann La Roche derivados de fenil metanona 2,5-di-substituìdos como inibidores do transportador de glicina 1 (glyt-1) para o tratamento de distúbios neurológicos e neuropsiquiátricos
ATE447572T1 (de) 2005-01-26 2009-11-15 Hoffmann La Roche Phenylmethanonderivate und ihre verwendung als glycin-transporter-1-hemmer
HRP20100076T1 (hr) * 2005-02-07 2010-03-31 F. Hoffmann - La Roche Ag Heterociklički supstituirani fenil metanoni kao inhibitori glicin transportera 1
CN100341871C (zh) * 2005-06-03 2007-10-10 复旦大学 含哌啶结构的有机硫化合物,制备方法和应用
WO2007110449A1 (fr) 2006-03-29 2007-10-04 Euro-Celtique S.A. Composés de benzènesulfonamide et utilisation de ceux-ci
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
US8791264B2 (en) 2006-04-13 2014-07-29 Purdue Pharma L.P. Benzenesulfonamide compounds and their use as blockers of calcium channels
MX2009004822A (es) * 2006-11-01 2009-10-19 Purdue Pharma Lp Compuestos de fenilpropionamida y usos de los mismos.
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
WO2008124118A1 (fr) 2007-04-09 2008-10-16 Purdue Pharma L.P. Composés benzènesulfonylés et leur utilisation
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
JP2011506441A (ja) * 2007-12-12 2011-03-03 アムジエン・インコーポレーテツド グリシン輸送体−1阻害薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
CA1140119A (fr) * 1978-04-03 1983-01-25 Joseph Torremans Nouvelles n-heterocycle-4-piperidinamines
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
AU1041599A (en) * 1997-11-13 1999-06-07 Jose Luis Castro Pineiro Therapeutic uses of triazolo-pyridazine derivatives

Also Published As

Publication number Publication date
EE200000482A (et) 2002-02-15
KR20010032968A (ko) 2001-04-25
JP2002505277A (ja) 2002-02-19
WO1999044596A3 (fr) 2000-02-17
BG104685A (en) 2001-04-30
PL343435A1 (en) 2001-08-13
BR9907951A (pt) 2001-01-30
HRP20000523A2 (en) 2001-02-28
WO1999044596A2 (fr) 1999-09-10
CA2322164A1 (fr) 1999-09-10
NO20004431D0 (no) 2000-09-05
NO20004431L (no) 2000-10-30
EP1059922A2 (fr) 2000-12-20
SK13082000A3 (sk) 2001-03-12
AU3408999A (en) 1999-09-20
HUP0101048A2 (hu) 2001-10-28
IL138228A0 (en) 2001-10-31
CN1292698A (zh) 2001-04-25

Similar Documents

Publication Publication Date Title
TR200002567T2 (tr) Glisin naklini önleyiciler.
TR200002570T2 (tr) Glisin naklini önleyiciler
EA200200183A1 (ru) Композиция, содержащая трамадол и противосудорожное лекарственное средство
IS1990B (is) Nýstárlegar staðgengnar hringamínósýrur notaðar til lyfjagerðar
IL125562A0 (en) Novel cyclic amino acids and pharmaceutical compositions comprising them
IL125364A0 (en) Novel bridged cyclic amino acids and pharmaceutical compositions containing them
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
HRP970560B1 (en) Substituted gamma aminobutyric acids as pharmaceutical agents
TW200505824A (en) Bicyclic amino acids as pharmaceutical agents
DE60142236D1 (de) Substituierte 5-alkinyl-pyrimidine mit neurotropher wirkung
DE59209704D1 (de) 2-Aminomethyl-chromane als Wirkstoffe in Arzneimitteln zur Behandlung von Erkrankungen des Zentralnervensystems
GB0129260D0 (en) Pharmaceutical compositions and their uses
DE69223965D1 (de) Anticonvulsives aminosäurederivat
NL300232I1 (nl) Gebruik van daptomycine.
BG102080A (en) Amino acid derivatives of substituted quinoxalin 2,3-dion derivatives such as glutamate receptor antagonists
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
IL164317A0 (en) Statin therapy for enhancing cognitive maintenance
WO2003037335A8 (fr) Pyrazoles substitues a 5 heteroatomes
NZ268914A (en) Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease
CA2245647A1 (fr) Nouveaux aminoacides cycliques pontes utilises comme agents pharmaceutiques